hydroxyurea has been researched along with Cognitive Decline in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, chorea is a rare complication of this disease, occurring in less than 5% of the patients." | 1.48 | Sudden hemichorea and frontal lobe syndrome: a rare presentation of unbalanced polycythaemia vera. ( Fernandez-Dominguez, J; García-Cabo, C; Mateos, V, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Youssry, I | 1 |
| ElGhamrawy, M | 1 |
| Seif, H | 1 |
| Balsamo, L | 1 |
| Pashankar, F | 1 |
| Mahrous, M | 1 |
| Salama, N | 1 |
| Karkoska, KA | 1 |
| Gollamudi, J | 1 |
| Hyacinth, HI | 1 |
| Longoria, JN | 1 |
| Pugh, NL | 1 |
| Gordeuk, V | 1 |
| Hsu, LL | 1 |
| Treadwell, M | 1 |
| King, AA | 1 |
| Gibson, R | 1 |
| Kayle, M | 1 |
| Crego, N | 1 |
| Glassberg, J | 1 |
| Melvin, CL | 1 |
| Hankins, JS | 1 |
| Porter, J | 1 |
| García-Cabo, C | 1 |
| Fernandez-Dominguez, J | 1 |
| Mateos, V | 1 |
| Casella, JF | 1 |
| Adams, RJ | 1 |
| Brambilla, DJ | 1 |
| Strouse, JJ | 1 |
| Maier, P | 1 |
| Dlugash, R | 1 |
| Avadhani, R | 1 |
| Vermillion, K | 1 |
| Tonascia, J | 1 |
| Voeks, JH | 1 |
| Hanley, DF | 1 |
| Thompson, RE | 1 |
| Lehmann, HP | 1 |
| Martin, S | 1 |
| Roderick, MC | 1 |
| Abel, C | 1 |
| Wolters, P | 1 |
| Toledo-Tamula, MA | 1 |
| Fitzhugh, C | 1 |
| Hsieh, M | 1 |
| Tisdale, J | 1 |
1 review available for hydroxyurea and Cognitive Decline
| Article | Year |
|---|---|
Molecular and environmental contributors to neurological complications in sickle cell disease.
Topics: Anemia, Sickle Cell; Blood Transfusion; Cognitive Dysfunction; Humans; Hydroxyurea; Stroke | 2023 |
1 trial available for hydroxyurea and Cognitive Decline
| Article | Year |
|---|---|
Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Cognitive Dysfunction; Executive Function; Female; | 2020 |
4 other studies available for hydroxyurea and Cognitive Decline
| Article | Year |
|---|---|
Prevalence and risk factors of cognitive impairment in children with sickle cell disease in Egypt.
Topics: Adolescent; Adult; Age Factors; Anemia, Sickle Cell; Biomarkers; Brain; Child; Cognition; Cognitive | 2022 |
Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease.
Topics: Activities of Daily Living; Adolescent; Adult; Anemia, Sickle Cell; Antisickling Agents; Cognitive D | 2021 |
Sudden hemichorea and frontal lobe syndrome: a rare presentation of unbalanced polycythaemia vera.
Topics: Aged, 80 and over; Brain; Chorea; Cognitive Dysfunction; Frontal Lobe; Humans; Hydroxyurea; Male; Po | 2018 |
Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.
Topics: Anemia, Sickle Cell; Child; Clinical Trials as Topic; Cognitive Dysfunction; Endpoint Determination; | 2019 |